UBS Group’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-272,900
Closed -$7.64M 9256
2023
Q3
$7.64M Hold
272,900
﹤0.01% 2198
2023
Q2
$8.54M Hold
272,900
﹤0.01% 2086
2023
Q1
$7.69M Hold
272,900
﹤0.01% 2115
2022
Q4
$7.13M Buy
+272,900
New +$6.53M ﹤0.01% 2172
2018
Q2
Sell
-25,000
Closed -$1.45M 7952
2018
Q1
$1.45M Buy
+25,000
New +$1.46M ﹤0.01% 3393
2016
Q2
Sell
-80,000
Closed -$2.73M 7684
2016
Q1
$2.73M Buy
+80,000
New +$3.16M ﹤0.01% 2394

Other funds holding ALKS

UBS Group's ALKS Position: Q1 2026 in Review

UBS Group reduced its Alkermes (ALKS) stake by 81% in Q1 2026, selling an estimated $63.6M and leaving 495,023 shares worth $17.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2732.

UBS Group first reported a position in ALKS in Q4 2014 and has held it in 46 quarters since. The position peaked at $100M in Q1 2025. 389 funds tracked by Wall St. Rank hold ALKS as of Q1 2026.

  • UBS Group held 495,023 shares of Alkermes worth $17.5M as of Q1 2026.
  • UBS Group sold 2,049,872 Alkermes shares in Q1 2026, an estimated $63.6M.
  • Alkermes made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #2732 holding.
  • UBS Group first reported a position in Alkermes in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Alkermes position peaked at $100M in Q1 2025.
  • 389 funds tracked by Wall St. Rank held Alkermes as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.